Svelte Medical Systems Announces Completion of 6-Month Follow ... | Telemedicine | Scoop.it
Svelte® Medical Systems today announced completion of primary endpoint 6-month follow-up in DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioresorbable drug Carrier Technology), a prospective, ...